logo
Verified
High Ratings
70+ Specializations
200+ Therapies
Research Phase I/II/III

About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study on REGN7508 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Bulgaria Hungary Latvia Lithuania Poland
  • Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Finland France Germany Greece Hungary +5
  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Italy Poland Spain
  • Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Germany Italy The Netherlands Poland Spain
  • Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +6
  • Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Estonia +14
  • Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +14
  • Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +2